首页> 外文期刊>Cancer immunology research. >Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent Pathway
【24h】

Circulating Tumor Microparticles Promote Lung Metastasis by Reprogramming Inflammatory and Mechanical Niches via a Macrophage-Dependent Pathway

机译:循环肿瘤微粒通过通过巨噬细胞依赖性途径重编程炎性和机械乳房促进肺转移

获取原文
获取原文并翻译 | 示例
           

摘要

Despite the frequency of lung metastasis and its associated mortality, the mechanisms behind metastatic tumor cell survival and colonization in the lungs remain elusive. Here, we show that tumor cell-released microparticles (T-MPs) from the primary tumor site play a critical role in the metastatic process. The T-MPs remodeled the lung parenchyma via a macrophage-dependent pathway to create an altered inflammatory and mechanical response to tumor cell invasion. Mechanistically, we show that circulating T-MPs readily enter the lung parenchyma where they are taken up by local macro-phages and induce CCL2 production. CCL2 recruits CD11b(+) Ly6C(high) inflammatory monocytes to the lungs where they mature into F4/80(+)CD11b(+)Ly6C(-) macrophages that not only produce IL6 but also trigger fibrin deposition. IL6 and the deposited fibrin facilitate the survival and growth of tumor-repopulating cells in the lungs by providing chemical and mechanical signals, respectively, thus setting the stage for lung metastasis. These data illustrate that T-MPs reprogram the lung microenvironment promoting metastasis. (C) 2018 AACR.
机译:尽管肺转移的频率及其相关的死亡率,但肺部转移肿瘤细胞存活和殖民化背后的机制仍然难以捉摸。在这里,我们表明,来自原发性肿瘤部位的肿瘤细胞释放的微粒(T-MPS)在转移过程中起重要作用。 T-MPS通过巨噬细胞依赖性途径重塑肺实质途径,以产生改变的炎症和对肿瘤细胞侵袭的机械反应。机械地,我们表明循环T-MPS容易进入肺部牙科,其中局部宏观噬菌体占据,并诱导CCL2生产。 CCL2招募CD11b(+)Ly6c(高)炎症单核细胞到肺部,它们成熟成F4 / 80(+)CD11b(+)Ly6c( - )巨噬细胞,其不仅产生IL6,而且引发纤维蛋白沉积。 IL6和沉积的纤维蛋白通过分别提供化学和机械信号,促进肿瘤重新灌注细胞的存活率和生长,从而设定肺转移的阶段。这些数据说明T-MPS重新编程促进转移的肺部微环境。 (c)2018年AACR。

著录项

  • 来源
    《Cancer immunology research.》 |2018年第9期|共11页
  • 作者单位

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Chinese Acad Med Sci Inst Basic Med Sci Dept Immunol Beijing Peoples R China;

    Huazhong Univ Sci &

    Technol Dept Biochem &

    Mol Biol Tongji Med Coll Wuhan Hubei Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号